Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
15.26
+0.89 (6.19%)
Feb 26, 2026, 4:00 PM EST - Market closed
Amylyx Pharmaceuticals Analyst Ratings
Total Analysts
8
Consensus Rating
Strong Buy
Price Target
$18.63
Upside
+22.08%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| B of A Securities | B of A Securities | Strong Buy Maintains $15 → $19 | Strong Buy | Maintains | $15 → $19 | +24.51% | Feb 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $28 | Strong Buy | Maintains | $20 → $28 | +83.49% | Feb 10, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $16 → $20 | Strong Buy | Maintains | $16 → $20 | +31.06% | Nov 7, 2025 |
| Citigroup | Citigroup | Strong Buy Maintains $12 → $20 | Strong Buy | Maintains | $12 → $20 | +31.06% | Oct 17, 2025 |
| Baird | Baird | Buy Maintains $10 → $19 | Buy | Maintains | $10 → $19 | +24.51% | Oct 16, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $14 → $16 | Strong Buy | Maintains | $14 → $16 | +4.85% | Oct 3, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $10 → $20 | Strong Buy | Maintains | $10 → $20 | +31.06% | Sep 16, 2025 |
| Guggenheim | Guggenheim | Strong Buy Maintains $17 → $25 | Strong Buy | Maintains | $17 → $25 | +63.83% | Sep 15, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $10 → $14 | Strong Buy | Maintains | $10 → $14 | -8.26% | Aug 28, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | -34.47% | Jul 10, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $17 | Strong Buy | Initiates | $17 | +11.40% | Jun 24, 2025 |
| Citigroup | Citigroup | Strong Buy Initiates $12 | Strong Buy | Initiates | $12 | -21.36% | Jun 17, 2025 |
| Mizuho | Mizuho | Buy Maintains $7 → $8 | Buy | Maintains | $7 → $8 | -47.58% | May 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $12 → $16 | Strong Buy | Maintains | $12 → $16 | +4.85% | May 9, 2025 |
| Leerink Partners | Leerink Partners | Hold → Buy Upgrades $4 → $10 | Hold → Buy | Upgrades | $4 → $10 | -34.47% | May 7, 2025 |
| Mizuho | Mizuho | Hold → Buy Upgrades $3 → $7 | Hold → Buy | Upgrades | $3 → $7 | -54.13% | Apr 7, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.